10-K Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001193125-12-517638`
Period End Date	20120930
Filing Date	20121228
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	arwr-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 103 Income Statement 89 Cash Flow Statement 146 Stockholders Equity 65

Balance Sheet 103 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Trade receivable	`AccountsReceivableNetCurrent`	$9.38K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other receivables	`OtherReceivables`	$9.93K	USD	Point-in-time
Other receivables	`OtherReceivables`	$1.61M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$110.82K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$618.13K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$106.50K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$634.59K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.58M	shares	Point-in-time
Note receivable, net	`NotesAndLoansReceivableNetCurrent`	$2.45M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.64M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7,054.00	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$9.86M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.58M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$6.57M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.64M	shares	Point-in-time
Computers, office equipment and furniture	`FurnitureAndFixturesGross`	$285.27K	USD	Point-in-time
Computers, office equipment and furniture	`FurnitureAndFixturesGross`	$323.38K	USD	Point-in-time
Research equipment	`ResearchEquipment`	$3.32M	USD	Point-in-time
Research equipment	`ResearchEquipment`	$3.52K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$69.62K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$77.02K	USD	Point-in-time
Leasehold improvements	`LeaseholdImprovementsGross`	$2.75M	USD	Point-in-time
Property, Plant and Equipment, Gross, Total	`PropertyPlantAndEquipmentGross`	$6.46M	USD	Point-in-time
Property, Plant and Equipment, Gross, Total	`PropertyPlantAndEquipmentGross`	$365.80K	USD	Point-in-time
Less: Accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$340.36K	USD	Point-in-time
Less: Accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.57M	USD	Point-in-time
PROPERTY AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$4.90M	USD	Point-in-time
PROPERTY AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$25.44K	USD	Point-in-time
Patents and other intangible assets, net	`FiniteLivedIntangibleAssetsGross`	$4.78M	USD	Point-in-time
Patents and other intangible assets, net	`FiniteLivedIntangibleAssetsGross`	$1.73M	USD	Point-in-time
Note receivable, net	`NotesAndLoansReceivableNetNoncurrent`	$2.27M	USD	Point-in-time
Investment in Nanotope Inc., equity basis	`EquityMethodInvestments`	$1.65M	USD	Point-in-time
Investment in Leonardo Biosystems Inc., at cost	`CostMethodInvestments`	$187.00K	USD	Point-in-time
Derivative asset and other non-current assets	`DerivativeAssetsNoncurrent`	$161.12K	USD	Point-in-time
Derivative asset and other non-current assets	`DerivativeAssetsNoncurrent`	$280.26K	USD	Point-in-time
TOTAL OTHER ASSETS	`OtherAssetsNoncurrent`	$5.06M	USD	Point-in-time
TOTAL OTHER ASSETS	`OtherAssetsNoncurrent`	$6.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$16.53M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$576.81K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$877.99K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$864.51K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$730.77K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.13M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$195.65K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$37.50K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$647.21K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$944.98K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$214.80K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.69M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$2.58M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$5.33M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$606.79K	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$839.42K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$1.28M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$135.66K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$269.14K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$2.39M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$742.45K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $ 0.001 par value; 145,000,000 shares authorized; 13,579,185 and 8,642,286 shares issued and outstanding as of September 30, 2012 and September 30, 2011, respectively	`CommonStockValue`	$86.42K	USD	Point-in-time
Common stock, $ 0.001 par value; 145,000,000 shares authorized; 13,579,185 and 8,642,286 shares issued and outstanding as of September 30, 2012 and September 30, 2011, respectively	`CommonStockValue`	$108.35K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$127.48M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$145.92M	USD	Point-in-time
Subscription receivable	`ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock`	$900.00K	USD	Point-in-time
Subscription receivable	`ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock`	$1.02M	USD	Point-in-time
Accumulated deficit during the development stage	`RetainedEarningsAccumulatedDeficit`	$-135.00M	USD	Point-in-time
Accumulated deficit during the development stage	`RetainedEarningsAccumulatedDeficit`	$-113.87M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$10.01M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$12.79M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-1.20M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-226.94K	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.23M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.46M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.08M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$28.03M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.42M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.61M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.30M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.86M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.89M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$16.53M	USD	Point-in-time

Income Statement 89 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$4.14M	USD	38 Qtrs
REVENUE	`Revenues`	$296.14K	USD	Annual
REVENUE	`Revenues`	$146.88K	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$26.39M	USD	38 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$6.41M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$1.41M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.44M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.80M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.35M	USD	38 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.39M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.28M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$42.62M	USD	38 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.38M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.24M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$13.58M	USD	38 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$267.98K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.41M	USD	38 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$121.35M	USD	38 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$10.13M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$21.24M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-9.83M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-117.22M	USD	38 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-21.09M	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-963.41K	USD	38 Qtrs
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-163.18K	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-240.15K	USD	Annual
Impairment of investment in unconsolidated affiliates	`ImpairmentOfInvestments`	$1.64M	USD	Annual
Impairment of investment in unconsolidated affiliates	`ImpairmentOfInvestments`	$1.64M	USD	38 Qtrs
Gain on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	38 Qtrs
Gain on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	Annual
Loss on sale of property and equipment, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.08M	USD	Annual
Loss on sale of property and equipment, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.21M	USD	38 Qtrs
Realized and unrealized gain (loss) on marketable securities	`MarketableSecuritiesGainLoss`	$-261.22K	USD	Annual
Realized and unrealized gain (loss) on marketable securities	`MarketableSecuritiesGainLoss`	$-58.09K	USD	Annual
Realized and unrealized gain (loss) on marketable securities	`MarketableSecuritiesGainLoss`	$62.95K	USD	38 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$35.97K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$86.53K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$2.75M	USD	38 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$3.28M	USD	38 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$386.89K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.13M	USD	Annual
Gain on sale of stock in subsidiary	`GainLossOnSaleOfStockInSubsidiary`	$2.29M	USD	38 Qtrs
Other income	`OtherIncome`	$250.00K	USD	Annual
Other income	`OtherIncome`	$250.00K	USD	38 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-1.02M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.05M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$6.40M	USD	38 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-110.81M	USD	38 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.11M	USD	Annual
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.79M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	38 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-22.11M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-110.81M	USD	38 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-8.79M	USD	Annual
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$1.37M	USD	Annual
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-47.55M	USD	38 Qtrs
Income (loss) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-80.00	USD	Annual
Gain on disposal of discontinued operations	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$4.71M	USD	38 Qtrs
Gain on disposal of discontinued operations	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$3.92M	USD	Annual
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-42.84M	USD	38 Qtrs
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-80.00	USD	Annual
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$5.29M	USD	Annual
NET LOSS	`ProfitLoss`	$-30.71M	USD	Annual
NET LOSS	`ProfitLoss`	$-751.25K	USD	Annual
NET LOSS	`ProfitLoss`	$-3.49M	USD	Annual
NET LOSS	`ProfitLoss`	$-27.24M	USD	Annual
NET LOSS	`ProfitLoss`	$-153.65M	USD	38 Qtrs
NET LOSS	`ProfitLoss`	$-22.11M	USD	Annual
NET LOSS	`ProfitLoss`	$-95.24K	USD	Annual
NET LOSS	`ProfitLoss`	$-19.96M	USD	Annual
NET LOSS	`ProfitLoss`	$-19.31M	USD	Annual
NET LOSS	`ProfitLoss`	$-6.96M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-984.79K	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.82M	USD	38 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-363.51K	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-3.13M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-134.83M	USD	38 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.73M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-21.13M	USD	Annual
Loss from continuing operations attributable to Arrowhead common shareholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.90	USD	Annual
Loss from continuing operations attributable to Arrowhead common shareholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.18	USD	Annual
Loss from discontinued operations attributable to Arrowhead common shareholders	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.74	USD	Annual
Net loss attributable to Arrowhead shareholders	`EarningsPerShareBasic`	$-1.90	USD	Annual
Net loss attributable to Arrowhead shareholders	`EarningsPerShareBasic`	$-0.44	USD	Annual
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.13M	shares	Annual
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	7.18M	shares	Annual

Cash Flow Statement 146 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-30.71M	USD	Annual
Net income (loss)	`ProfitLoss`	$-751.25K	USD	Annual
Net income (loss)	`ProfitLoss`	$-3.49M	USD	Annual
Net income (loss)	`ProfitLoss`	$-27.24M	USD	Annual
Net income (loss)	`ProfitLoss`	$-153.65M	USD	38 Qtrs
Net income (loss)	`ProfitLoss`	$-22.11M	USD	Annual
Net income (loss)	`ProfitLoss`	$-95.24K	USD	Annual
Net income (loss)	`ProfitLoss`	$-19.96M	USD	Annual
Net income (loss)	`ProfitLoss`	$-19.31M	USD	Annual
Net income (loss)	`ProfitLoss`	$-6.96M	USD	Annual
Net (income) loss attributable to nonconrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-984.79K	USD	Annual
Net (income) loss attributable to nonconrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.82M	USD	38 Qtrs
Net (income) loss attributable to nonconrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-363.51K	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-3.13M	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-134.83M	USD	38 Qtrs
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-6.73M	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-21.13M	USD	Annual
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-42.84M	USD	38 Qtrs
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$5.29M	USD	Annual
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-80.00	USD	Annual
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$-261.22K	USD	Annual
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$-58.09K	USD	Annual
Realized and unrealized (gain) loss on investments	`GainLossOnSaleOfInvestments`	$762.95K	USD	38 Qtrs
Charge for bad debt allowance	`ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances`	$2.50M	USD	38 Qtrs
Charge for bad debt allowance	`ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances`	$2.50M	USD	Annual
(Gain) loss from sale of subsidiary	`GainLossFromSaleOfSubsidiary`	$306.34K	USD	38 Qtrs
(Gain) loss on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	38 Qtrs
(Gain) loss on purchase of Roche Madison	`GainOnAcquisition`	$1.58M	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.08M	USD	Annual
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.21M	USD	38 Qtrs
Stock issued for professional services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$193.88K	USD	Annual
Stock issued for professional services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$741.63K	USD	38 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$3.28M	USD	38 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$386.89K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.13M	USD	Annual
Purchased in-process research and development	`ResearchAndDevelopmentInProcess`	$15.85M	USD	38 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.38M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.24M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$13.58M	USD	38 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$267.98K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.41M	USD	38 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.75M	USD	Annual
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$-7.94K	USD	Annual
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$9.39K	USD	Annual
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$1.45K	USD	38 Qtrs
Purchase of common shares	`CommonStockPurchasedFromMinorityShareHolders`	200,000.00	shares	Point-in-time
Gain on sale of stock in subsidiary	`GainLossOnSaleOfStockInSubsidiary`	$2.29M	USD	38 Qtrs
Common stock, shares issued	`CommonStockSharesIssued`	13.58M	shares	Point-in-time
Non-cash impairment expense	`NonCashImpairmentCharges`	$1.64M	USD	Annual
Common stock, shares issued	`CommonStockSharesIssued`	8.64M	shares	Point-in-time
Non-cash impairment expense	`NonCashImpairmentCharges`	$1.64M	USD	38 Qtrs
Common stock, shares issued	`CommonStockSharesIssued`	7,054.00	shares	Point-in-time
Common stock value	`CommonStockValue`	$86.42K	USD	Point-in-time
Equity in (income)loss of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-240.15K	USD	Annual
Equity in (income)loss of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-963.41K	USD	38 Qtrs
Common stock value	`CommonStockValue`	$108.35K	USD	Point-in-time
Equity in (income)loss of unconsolidated affiliates	`GainLossOnSaleOfEquityInvestments`	$-163.18K	USD	Annual
Noncontrolling interest	`NoncontrollingInterest`	$18.82M	USD	38 Qtrs
Noncontrolling interest	`NoncontrollingInterest`	$363.51K	USD	Annual
Noncontrolling interest	`NoncontrollingInterest`	$984.79K	USD	Annual
Stock purchased by cash	`ValueOfCommonStockPurchasedByCash`	$200.00K	USD	Point-in-time
Receivables	`IncreaseDecreaseInReceivables`	$-100.04K	USD	38 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-162.85K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$2.54M	USD	38 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$736.25K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$938.18K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$338.53K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$481.10K	USD	38 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-99.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-18.47K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$6.85K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$103.21K	USD	38 Qtrs
Deposits	`IncreaseDecreaseInDeposits`	$-23.75K	USD	Annual
Warrants exercised	`WarrantsExercised`	24,788.00	shares	Point-in-time
Deposits	`IncreaseDecreaseInDeposits`	$-60.54K	USD	38 Qtrs
Stock issued against warrants	`StockIssuedAgainstWarrants`	12,870.00	shares	Point-in-time
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$291.88K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$498.31K	USD	38 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$157.08K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$452.84K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$186.37K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$720.91K	USD	38 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$882.30K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$15.75K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.13M	USD	38 Qtrs
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-15.34M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.66M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-75.88M	USD	38 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$479.71K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.05M	USD	38 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.67K	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$509.01K	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$3.31M	USD	38 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.53M	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$432.69K	USD	38 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$290.31K	USD	Annual
Cash transferred in acquisition/divestitures	`CashDivestedFromDeconsolidation`	$1.58M	USD	38 Qtrs
Cash transferred in acquisition/divestitures	`CashDivestedFromDeconsolidation`	$1.70M	USD	Annual
Cash transferred in acquisition/divestitures	`CashDivestedFromDeconsolidation`	$-121.03K	USD	Annual
Purchase of marketable securities-US Treasury Bills	`PaymentsToAcquireMarketableSecurities`	$18.58M	USD	38 Qtrs
Purchase of MASA Energy, LLC	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00K	USD	38 Qtrs
Minority equity investment	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$2.00M	USD	38 Qtrs
Cash paid for interest in Insert	`PaymentsToAcquireInterestInSubsidiariesAndAffiliates`	$10.15M	USD	38 Qtrs
Cash obtained from interest in Insert	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	$10.53M	USD	38 Qtrs
Proceeds from sale of marketable securities-US Treasury Bills	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.89M	USD	38 Qtrs
Proceeds from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries`	$359.38K	USD	38 Qtrs
Payment for patents	`PaymentsToAcquireIntangibleAssets`	$303.44K	USD	38 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$-50.77K	USD	38 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.33M	USD	38 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$440.64K	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-175.38K	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$196.61K	USD	38 Qtrs
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$196.61K	USD	Annual
Proceeds from issuance of Calando debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.52M	USD	38 Qtrs
Proceeds from issuance of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$8.00K	USD	Annual
Proceeds from issuance of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$1.72M	USD	Annual
Proceeds from issuance of stock in subsidiary	`ProceedsFromSaleOfStockInSubsidiary`	$20.90M	USD	38 Qtrs
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$10.96M	USD	Annual
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$4.51M	USD	Annual
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$106.25M	USD	38 Qtrs
Proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$6.20M	USD	Point-in-time
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$129.47M	USD	38 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.23M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.77M	USD	Annual
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-46.00M	USD	38 Qtrs
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-280.00	USD	Annual
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$2.27M	USD	Annual
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$790.62K	USD	38 Qtrs
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$-1.68M	USD	38 Qtrs
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-46.89M	USD	38 Qtrs
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-280.00	USD	Annual
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$2.27M	USD	Annual
NET INCREASE(DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.13M	USD	Annual
NET INCREASE(DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.38M	USD	38 Qtrs
NET INCREASE(DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$660.23K	USD	Annual
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.85M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
Interest paid	`InterestPaid`	$46.27K	USD	Annual
Interest paid	`InterestPaid`	$280.69K	USD	38 Qtrs
Interest paid	`InterestPaid`	$105.00K	USD	Annual
Taxes paid	`IncomeTaxesPaid`	$742.50K	USD	Annual
Taxes paid	`IncomeTaxesPaid`	$742.50K	USD	38 Qtrs

Stockholders Equity 65 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.23M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.46M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.08M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$28.03M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.42M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.61M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.30M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.86M	USD	Point-in-time
Stock issuances	`StockIssuedDuringPeriodValueNewIssues`	$50.41K	USD	Annual
Stock issuances	`StockIssuedDuringPeriodValueNewIssues`	$50.00K	USD	Annual
Stock issuances	`StockIssuedDuringPeriodValueNewIssues`	$1.07M	USD	Annual
Stock issuances	`StockIssuedDuringPeriodValueNewIssues`	$43.28K	USD	Annual
Reclassification of former Unidym mezzanine debt to equity	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$2.00M	USD	Annual
Issuance and sold of Common Stock	`StockIssuedDuringPeriodSharesNewIssues`	2.26M	shares	Point-in-time
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$23.83K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.00K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$290.03K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.63K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.88K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$341.54K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$434.73K	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	4,883.00	shares	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,699.00	shares	Annual
Stock issuance cost charged to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$991.32K	USD	Annual
Divestiture of Unidym	`MinorityInterestIncreaseFromStockIssuance`	$254.28K	USD	Annual
Divestiture of Unidym	`MinorityInterestIncreaseFromStockIssuance`	$300.00K	USD	Annual
Issuance of preferred stock in subsidiary	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$-1.62M	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$16.30K	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$2.40M	USD	Annual
Adjustments to additional paid in capital, reallocation of noncontrolling interest	`AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest`	$230.09K	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$508.51K	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$175.65K	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.40M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.24M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.37M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.58M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.19M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.18M	USD	Annual
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.68M	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-3.13M	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-134.83M	USD	38 Qtrs
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-6.73M	USD	Annual
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-21.13M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-30.71M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-751.25K	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-3.49M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-27.24M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-153.65M	USD	38 Qtrs
Net loss attributable to Arrowhead	`ProfitLoss`	$-22.11M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-95.24K	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-19.96M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-19.31M	USD	Annual
Net loss attributable to Arrowhead	`ProfitLoss`	$-6.96M	USD	Annual
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.23M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.46M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.08M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$28.03M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.42M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$31.61M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.30M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.56M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.86M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.